Holen Sie sich die Stockscreener-App
13.24
1.27%
-0.17
Handel nachbörslich:
13.25
0.010
+0.08%
Tonix Pharmaceuticals Holding Corp Aktie (TNXP) Neueste Nachrichten
Tonix Pharmaceuticals Says Prescriptions For Chronic Pain Drug Top 4,200 Since Launch - Benzinga
Tonix Pharmaceuticals reports $13.1M product revenue, $124.0M net loss for FY2025 - TradingView
Tonix Pharmaceuticals (TNXP) Reports Mixed Q4 Results with Reven - GuruFocus
Tonix Pharma earnings missed by $0.79, revenue topped estimates - Investing.com Nigeria
Tonix (TNXP) Sees Transformational Year with FDA Approval and St - GuruFocus
Tonix Pharmaceuticals Wins FDA Approval for TONMYA in Fibromyalgia and Expands CNS, Immunology, and Rare Disease Pipeline - Minichart
Tonix Pharmaceuticals (NASDAQ:TNXP) Releases Earnings Results, Misses Estimates By $0.99 EPS - MarketBeat
Tonix Pharmaceuticals Holding 2025 10-K — Revenue $13.1M, EPS (14.57) - TradingView
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights - Yahoo Finance
Aug Chart Watch: What are the future prospects of Tonix Pharmaceuticals Holding CorpTrade Entry Report & Daily Growth Stock Investment Tips - baoquankhu1.vn
TNXP: New fibromyalgia drug launch shows positive uptake; Lyme prevention antibody advances in pipeline - TradingView
Tonix presents fibromyalgia drug data at Poland conference By Investing.com - Investing.com South Africa
B2i Digital Highlights Life Sciences Virtual Investor Forum as a Featured Conference - TradingView
TONMYA™ (Cyclobenzaprine HCl Sublingual Tablets) Approved by FDA for Fibromyalgia—Tonix Pharmaceuticals Presents Positive Phase 3 Data Showing Rapid Pain Relief and Favorable Benefit-Risk Profile - Minichart
Tonix Pharmaceuticals (TNXP) Highlights New Findings on Tonmya a - GuruFocus
Tonix Pharma Highlights Positive Phase 3 Fibromyalgia Data - TipRanks
Tonix presents fibromyalgia drug data at Poland conference - Investing.com
Tonix Pharmaceuticals presents Phase 3 post hoc data showing rapid, significant pain relief with TONMYA - TradingView
Tonix Pharmaceuticals Presented Post Hoc Analyses of Phase 3 Data on TONMYATM at the 8th International Congress on Controversies in Fibromyalgia - The Manila Times
First new fibromyalgia drug in 15 years shows pain relief by Day 2 - Stock Titan
Tonix Pharmaceuticals (TNXP) Expected to Announce Earnings on Tuesday - MarketBeat
Tonix Pharmaceuticals Presented Data on TONMYA™ in Treating Patients with Fibromyalgia at the 2026 AAPM PainConnect Annual Meeting - The Manila Times
Tonix Pharmaceuticals Presented Data on TONMYATM in Treating Patients with Fibromyalgia at the 2026 AAPM PainConnect Annual Meeting - The Manila Times
New fibromyalgia drug Tonmya cuts pain in 14-week trial - Stock Titan
Is Tonix Pharmaceuticals Holding Corp stock a hidden gem2026 Growth vs Value & High Win Rate Trade Tips - baoquankhu1.vn
Is Tonix Pharmaceuticals Holding Corp. stock safe for conservative investors2026 Sector Review & Real-Time Volume Triggers - Naître et grandir
Tonix Pharmaceuticals Announces Publication of Clinical Pharmacokinetic Studies of TONMYA™ and Prototype Formulations in the Journal Clinical Pharmacology in Drug Development - Sahm
TNXP: Tonix Pharmaceuticals Shares Promising Results from Clinical Studies - GuruFocus
TONMYA fibromyalgia tablet under tongue bypasses first-pass liver metabolism - Stock Titan
Tonix Pharmaceuticals Announces Publication of Clinical - GlobeNewswire
Tonix Pharmaceuticals: Tonmya launches for fibromyalgia as pipeline advances toward key 2027 milestones - TradingView
Tonix Pharmaceuticals moves to Nasdaq Global Select Market - Investing.com Australia
Tonix Pharmaceuticals to Present Poster on Tonmya™ at the 2026 American Academy of Pain Medicine PainConnect Annual Meeting - The Manila Times
Tonix Pharmaceuticals to Present Poster on Tonmya at the 2026 American Academy of Pain Medicine PainConnect Annual Meeting - Bitget
Tonix Pharmaceuticals to Present Poster on Tonmya™ at the - GlobeNewswire
Tonix Pharmaceuticals Announces Uplisting From Nasdaq Capital Market to Nasdaq Global Select Market - 富途牛牛
Tonix Pharma Uplists to Nasdaq Global Select Market - TipRanks
Tonix Pharmaceuticals announces uplisting from Nasdaq Capital Market to Nasdaq Global Select Market - marketscreener.com
Tonix Pharmaceuticals Moves Listing to Nasdaq Global Select Market - marketscreener.com
Tonix Pharmaceuticals (TNXP) Moves to Nasdaq Global Select Marke - GuruFocus
Tonix Pharmaceuticals approved to transfer listing to Nasdaq Global Select Market - TradingView
Tonix Pharmaceuticals moves to Nasdaq Global Select Market By Investing.com - Investing.com UK
Tonix Pharmaceuticals (NASDAQ: TNXP) uplists to Nasdaq Global Select tier - Stock Titan
Biotech Tonix joins Nasdaq’s top tier, which may boost visibility - Stock Titan
Avoiding Lag: Real-Time Signals in (TNXP) Movement - Stock Traders Daily
Tonix Pharmaceuticals : March 2026 Investor Deck - marketscreener.com
Tonix Pharmaceuticals to Participate in Two Investor Conferences in March - Sahm
TNXP Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Tonix (TNXP) COO awarded two stock option grants under 2020 plan - Stock Titan
Tonix (TNXP) CFO granted stock options with multi-year vesting - Stock Titan
Tonix Pharmaceuticals (TNXP) CMO granted two new stock option awards - Stock Titan
Tonix Pharmaceuticals (TNXP) CTO receives two new stock option grants - Stock Titan
Tonix Pharmaceuticals (TNXP) CEO awarded new multi-year stock option grants - Stock Titan
TNXP Stock Price, Forecast & Analysis | TONIX PHARMACEUTICALS HOLDIN (NASDAQ:TNXP) - ChartMill
Tonix Pharmaceuticals to Participate in Upcoming Investor Conferences in March 2026 - Quiver Quantitative
Fibromyalgia drug maker Tonix to brief investors at March conferences - Stock Titan
Tonix Pharmaceuticals: Financial Runway and Pipeline Progress Under Scrutiny - AD HOC NEWS
Discipline and Rules-Based Execution in TNXP Response - Stock Traders Daily
Is Tonix Pharmaceuticals Holding Corp. forming a breakout pattern2025 Breakouts & Breakdowns & Weekly Watchlist of Top Performers - mfd.ru
Aug Catalysts: Will Tonix Pharmaceuticals Holding Corp announce a stock split2025 Technical Patterns & Daily Volume Surge Trade Alerts - baoquankhu1.vn
What is the PEG ratio of Tonix Pharmaceuticals Holding Corp.2025 Volatility Report & Accurate Entry and Exit Point Alerts - mfd.ru
TNXP PE Ratio & Valuation, Is TNXP Overvalued - Intellectia AI
What are Tonix Pharmaceuticals Holding Corp.’s earnings expectationsSwing Trade & Community Trade Idea Sharing Platform - mfd.ru
TNXP News Today | Why did Tonix Pharmaceuticals stock go up today? - MarketBeat
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):